Ann: Appendix 3B - Performance Rights and Options, page-8

First 8 Last

Share
Profile

Follow
Rajenp5

1,801 Posts.

5

07/08/17

13:03

Post #: 26336133
Share

Originally posted by Fire Bull ↑

There are two things that need to be addressed for this to trade on a decent profit multiple.

1) They need to stop diluting shareholders with all these options and performance rights. Ironically, the performance rights are designed to align the interests of management with shareholders and improve the share price. At least with cash bonuses there is no dilution, performance rights incur both a cost and erode shareholder capital.

I note the 6 million performance rights issued as per this announcement don't even include Domenic Carosa so we can expect another hit later in the year.

Then there are all these bonus options issued to financiers. In fact, the borrowing costs in general are very high given interest rates are so low at the moment. For example the JGB convertible notes were already costing 15% per anum before the extra options issued as per this announcement.

"The headline coupon rate is 6.25% although the effective finance cost (which depends on the facility usage) is estimated at 15.0% per annum, inclusive of cash premiums, originating issuer discount and JGB’s conversion right."

2) They need to pay down all the debt and not borrow anymore unless they can do so on less punitive terms. According to the latest update this will take 14 months and after this they should be able to finance future growth from the $8m cash flows they generate each year but I'm not holding my breath.

I hoped that having an institution on board would help address these issues but this announcement suggests nothing has changed.

Expand

Lord, turn your back on this Coy for a minute and they dilute. LOL. How many times is that now over the last year? 10X? Must be close to.

CM8 Price at posting: 19.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 1 more message in this thread...

First 8 Last

Add CM8 (ASX) to my watchlist

Ann: Appendix 3B - Performance Rights and Options, page-8

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News